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Oxytocin (OXT) is used on approximately 43% of women who give birth in the U.S. 
to induce or augment labor. The maximum OXT dose varies between women from ≤ 
2mU/min to ≥ 20mU/min. Those requiring ≥ 20mU/min of OXT are defined as “high-
dose requiring (HDR).” The biological cause underlying these individual differences in 
OXT response is unknown, however, maternal genetics is suspected to be a factor. Our 
laboratory has identified three variants (H173R, R150L, and R151C) in the oxytocin 
receptor (OXTR) gene in women who are HDR. H173R, R150L, and R151C were 
located in the binding and signaling domains of the OXTR and were predicted by SIFT 
(“Sorting Intolerant From Tolerant”) algorithm to be damaging to protein function. 
Another variant, A218T, was identified in approximately 22% of HDR and LDR women 
but predicted to be non-damaging to protein function. We hypothesized that the variants 
found in HDR individuals and predicted to be damaging would attenuate OXTR 
signaling. OXTR variants were created via mutagenesis and transfected into HEK293T 
and hTERT cells. Monoclonal HEK293 cell lines stably expressing wild-type (WT) 
OXTR and R150L+A218T OXTR were generated. The OXTR signaling ability of the WT 
and variants was assessed with an ELISA assay using IP1 accumulation as the readout for 
OXTR signaling. Calcium imaging was also used to measure OXTR function.
WT OXTR were functional as measured by the ELISA and calcium imaging. Higher 
doses of OXT led to greater stimulation of the OXTR and greater IP1 accumulation in 
cells transfected with WT OXTR. Cells stably expressing R150L+A218T OXTR were 
found to produce less IP1 compared to the WT OXTR. Our studies show that genetic 
variants found in HDR individuals may attenuate OXTR signaling. If so, this may help 
improve clinical methods and treatments using OXT during labor and delivery.
